Differential expression of DHHC9 in microsatellite stable and instable human colorectal cancer subgroups

作者: F Mansilla , K Birkenkamp-Demtroder , M Kruhøffer , F B Sørensen , C L Andersen

DOI: 10.1038/SJ.BJC.6603818

关键词:

摘要: Microarray analysis on pooled samples has previously identified ZDHHC9 (DHHC9) to be upregulated in colon adenocarcinoma compared normal mucosa. Analyses of 168 from proximal and distal adenocarcinomas using U133plus2.0 microarrays validated these findings, showing a significant two-fold (log 2) upregulation DHHC9 transcript (P<10−6). The was more striking microsatellite stable (MSS), than instable (MSI), tumours. Genes known interact with as H-Ras or N-Ras did not show expression differences between MSS MSI. Immunohistochemical performed 60 adenocarcinomas, analysed microarrays, well tissue 40 stage I–IV tumours 46 different organ sites. protein strongly expressed MSI tumours, readily detectable premalignant lesions, the rare seen specific for gastrointestinal tract localised Golgi apparatus, vitro vivo. Overexpression decreased proliferation SW480 CaCo2 cell lines significantly. In conclusion, is gastrointestinal-related highly palmitoyl transferase activity, modifying H-Ras, suggests target anticancer drug design.

参考文章(31)
Kevin G. Waddick, Fatih M. Uckun, Innovative treatment programs against cancer: I. Ras oncoprotein as a molecular target Biochemical Pharmacology. ,vol. 56, pp. 1411- 1426 ,(1998) , 10.1016/S0006-2952(98)00211-1
Tamotsu Sugai, Wataru Habano, Yu-Fei Jiao, Mitsunori Tsukahara, Yuichiro Takeda, Koki Otsuka, Shin-ichi Nakamura, Analysis of Molecular Alterations in Left- and Right-Sided Colorectal Carcinomas Reveals Distinct Pathways of Carcinogenesis: Proposal for New Molecular Profile of Colorectal Carcinomas The Journal of Molecular Diagnostics. ,vol. 8, pp. 193- 201 ,(2006) , 10.2353/JMOLDX.2006.050052
Wei Lv, RNAi technology: A Revolutionary tool for the colorectal cancer therapeutics World Journal of Gastroenterology. ,vol. 12, pp. 4636- 4639 ,(2006) , 10.3748/WJG.V12.I29.4636
A. J. Clark, R. Barnetson, S. M. Farrington, M. G. Dunlop, Prognosis in DNA mismatch repair deficient colorectal cancer: are all MSI tumours equivalent? Familial Cancer. ,vol. 3, pp. 85- 91 ,(2002) , 10.1023/B:FAME.0000039915.94550.CC
J. Feng, F. Hua, R. Shuo, G. Chongfeng, X. Huimian, T. Nakajima, W. Subao, N. Tsuchida, Upregulation of non-mutated H-ras and its upstream and downstream signaling proteins in colorectal cancer Oncology Reports. ,vol. 8, pp. 1409- 1413 ,(2001) , 10.3892/OR.8.6.1409
Oliver Rocks, Anna Peyker, Martin Kahms, Peter J Verveer, Carolin Koerner, Maria Lumbierres, Jürgen Kuhlmann, Herbert Waldmann, Alfred Wittinghofer, Philippe IH Bastiaens, An Acylation Cycle Regulates Localization and Activity of Palmitoylated Ras Isoforms Science. ,vol. 307, pp. 1746- 1752 ,(2005) , 10.1126/SCIENCE.1105654
Eric R. Fearon, Bert Vogelstein, A genetic model for colorectal tumorigenesis Cell. ,vol. 61, pp. 759- 767 ,(1990) , 10.1016/0092-8674(90)90186-I
Daniele M. Leonard, Ras farnesyltransferase: a new therapeutic target Journal of Medicinal Chemistry. ,vol. 40, pp. 2971- 2990 ,(1997) , 10.1021/JM970226L
John T. Swarthout, Sandra Lobo, Lynn Farh, Monica R. Croke, Wendy K. Greentree, Robert J. Deschenes, Maurine E. Linder, DHHC9 and GCP16 Constitute a Human Protein Fatty Acyltransferase with Specificity for H- and N-Ras Journal of Biological Chemistry. ,vol. 280, pp. 31141- 31148 ,(2005) , 10.1074/JBC.M504113200
Eiji Ohta, Yoshio Misumi, Miwa Sohda, Toshiyuki Fujiwara, Akiko Yano, Yukio Ikehara, Identification and characterization of GCP16, a novel acylated Golgi protein that interacts with GCP170. Journal of Biological Chemistry. ,vol. 278, pp. 51957- 51967 ,(2003) , 10.1074/JBC.M310014200